SCIENOPS / THERAPEUTIC CONTEXT
Assess evidence in relation to the disease, patient population, modality and intended use, with methods and reviewers appropriate to the programme.
ONCOLOGY
Frame questions around biomarkers, model relevance and variation across disease settings. Evaluate which findings support the proposed programme and which require additional evidence in the relevant context.
NEUROLOGY
Connect mechanism, model endpoints, exposure and clinical interpretation. Identify the assumptions involved in translating an experimental or computational result to the proposed use.
IMMUNOLOGY
Review pathway response, biomarker interpretation and safety considerations in the relevant setting. Treat context as part of the scientific question, since apparently similar responses can have different explanations.
OTHER PROGRAMME CONTEXTS
Rare-disease and modality-specific work may require different evidence, analytical methods and review standards. Confirm the relevant expertise and current capabilities before defining an engagement.
WHAT THIS PAGE REPRESENTS
These examples frame R&D discussions; they do not establish validated therapeutic expertise or clinical efficacy. Any consequential use requires the relevant specialist review and validation. The work described here is not individual-patient treatment selection.
